26 April 2020 - Other countries might not be quick to share. Time to speed up trials and ramp up manufacturing scale.

The first nation to develop a vaccine for COVID-19 could have an economic advantage as well as a tremendous public-health achievement. 

Doses will be limited initially as suppliers ramp up, and a country will focus on inoculating most of its own population first.

Read Wall Street Journal article